Why You Should Avoid These 2 Auto Stocks In The Second Half of 2026

Lucid Group is the clear underperformer: Q1 2026 production was 4,774 vehicles vs. Tesla’s 451,758, the stock is down ~99% from its all-time high, and it suspended full-year production guidance after bringing in a new CEO. Lucid also sold only ~80% of what it built and continues to lose money on every car sold, implying weak margins and execution risk into 2H 2026. O’Reilly Automotive is comparatively solid (Q1 2026 sales +8%, earnings +16%) but still screens expensive on valuation (P/E ~29x vs. ~26x 5-year avg; forward P/E ~28x vs. ~24x long-term avg), suggesting a cautious “watch for a better entry” stance rather than an immediate buy.

Analysis

ORLY remains the cleaner business, but the market is already paying for quality. The key mechanism is not near-term earnings surprise; it is whether the aftermarket can keep compounding while the multiple stays anchored near premium territory. If used-car affordability stays tight and the average vehicle age keeps drifting up, parts demand stays resilient, but margin upside is limited because labor, freight, and commercial-service competition can absorb most of the operating leverage. In other words: good business, mediocre risk/reward unless the pullback deepens.

LCID is a financing problem disguised as an operating problem. When a name is producing far below fixed-cost absorption, every quarter of underutilized capacity widens the cash burn gap and increases dilution odds; the stock’s main catalyst path is not unit growth, but some combination of restructuring, strategic capital, or a price cut that hurts economics further. The new management turnover is usually bullish only if it is followed by credible gross-margin improvement within 1-2 quarters; absent that, the equity remains a call option on survival with a poor strike price.

Contrarian read: the market may be underestimating how defensive ORLY is if macro softens, because a weaker consumer often shifts dollars from new-car purchases to maintenance. The market may also be overestimating how much benefit a leadership reset can create at LCID without scale; a better CEO does not fix negative contribution margin. The next hard test is the coming earnings/guidance cycle: if ORLY reaccelerates comps, the drawdown is buyable; if LCID avoids a financing event and gross loss narrows materially, the short becomes crowded. Until then, the asymmetry still favors quality over turnaround.

Key Decisions for Investors

• Hold off on chasing ORLY here; start a buy-wishlist around a further 8-12% pullback or if forward P/E compresses closer to its long-run average. Falsifier: next quarter comp/EBIT margin deceleration.
• Initiate a tactical short LCID or buy 3-6 month put spreads on strength; thesis is dilution/financing risk, not day-to-day production noise. Falsifier: credible path to gross profit plus no equity raise.
• Pair trade: long ORLY / short LCID as a quality-vs-distress spread for 1-3 months. Keep size modest because ORLY’s valuation limits upside, while LCID’s downside is driven by capital structure risk.
• Set an alert for LCID capital-market activity or revised guidance; any rally into such an event is likely a sell-the-news opportunity unless margin metrics improve.